http://www.w3.org/ns/prov#value | - These treatment effects were notably significant among patients who were not carriers of the apolipoprotein E4 allele (APOE4), a genetic risk factor associated with a higher probability of developing AD. Approximately 50% of individuals diagnosed with probable AD are estimated to be APOE4 positive.
|